Health Tourism: Opportunities, Constraints, Obstacles and Solutions
Authors
Abstract:
This article doesn't have abstract
similar resources
Electronic Markets in Tourism - Constraints and Opportunities
line reservation networks, known as CRSs or GDSs, extensively used by travel agencies worldwide, many factors have combined to inhibit the development of flourishing electronic markets serving the tourist and the tourism industry. It is certainly true that the airline GDSs provide something approaching a true electronic marketplace in the United States, where 95% of all airline tickets are sold...
full textObstacles and Opportunities
Management theory teaches that successful innovation requires concomitant changes among the system ’ s components to achieve congruence or fi t . 1 Similar thinking has been applied to changing the U.S. health care system. 2 In recent years, there has been growing recognition that payment reform of the U.S. health care system must be accompanied by corresponding reforms in the delivery system. ...
full textNeuroepigenomics: resources, obstacles, and opportunities
Long-lived post-mitotic cells, such as the majority of human neurons, must respond effectively to ongoing changes in neuronal stimulation or microenvironmental cues through transcriptional and epigenomic regulation of gene expression. The role of epigenomic regulation in neuronal function is of fundamental interest to the neuroscience community, as these types of studies have transformed our un...
full textObstacles and opportunities in Chinese pharmaceutical innovation
BACKGROUND Global healthcare innovation networks nowadays have expanded beyond developed countries with many developing countries joining the force and becoming important players. China, in particular, has seen a significant increase in the number of innovative firms and research organizations stepping up to the global network in recent years. Nevertheless, the intense Research and Development ...
full textBecoming accountable—opportunities and obstacles for ACOs.
n engl j med 363;15 nejm.org october 7, 201
full textClinical Trial Accrual: Obstacles and Opportunities
Less than 2% of patients diagnosed with cancer participate in a clinical trial in the United States (1). Gynecologic oncology patients do not appear to participate in trials with any more frequently than other cancer types. While gains in progression free survival have continued to improve overall life span for women with advanced gynecologic cancers, more cures have not been realized. Clinical...
full textMy Resources
Journal title
volume 4 issue 1
pages 37- 38
publication date 2016-03-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023